Synthon Biopharmaceuticals announces promising results with its antibody-drug conjuga

[News]

Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, has reported promising results with its lead program of antibody-drug conjugates (ADCs).

More... (http://www.news-medical.net/news/20130122/Synthon-Biopharmaceuticals-announces-promising-results-with-its-antibody-drug-conjugate-program.aspx)

[Ellie F]

Thanks for posting . This looks very interesting especially low toxicity and efficacy against her 2 .
Ellie